Regimen of 5-Fluorouracil and Cisplatin Increases the Incidence of Extravasation in Patients Undergoing Chemotherapy.

Tagashira, Hisashi; Izushi, Yasuhisa; Ikuta, Tomoki; Koike, Yasumasa; Kitamura, Yoshihisa; Yamamoto, Hiroshi

Tagashira, Hisashi; Izushi, Yasuhisa; Ikuta, Tomoki; Koike, Yasumasa; Kitamura, Yoshihisa; Yamamoto, Hiroshi.

Afiliación

Tagashira H; Department of Pharmacy, National Hospital Organization Okayama Medical Centre, Okayama, Japan; tagashira.hisashi.je@mail.hosp.go.jp.
Izushi Y; Department of pharmacotherapy, School of Pharmacy, Shujitsu University, Okayama, Japan.
Ikuta T; Division of Molecular and Cellular Medicine, Department of Clinical Science, National Hospital Organization Okayama Medical Centre, Okayama, Japan.
Koike Y; Department of Pharmacy, National Hospital Organization Shikoku Cancer Centre, Ehime, Japan.
Kitamura Y; Department of Pharmacy, National Hospital Organization Shikoku Cancer Centre, Ehime, Japan.
Yamamoto H; Department of pharmacotherapy, School of Pharmacy, Shujitsu University, Okayama, Japan.

In Vivo ; 35(2): 1147-1150, 2021.

Article en En | MEDLINE | ID: mdl-33622913

Asunto(s)

Cisplatino; Fluorouracilo; Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos; Cisplatino/efectos adversos; Fluorouracilo/efectos adversos; Humanos; Incidencia; Calidad de Vida

Palabras clave

5-Fluorouracil and cisplatin; chemotherapy; extravasation; regimen

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cisplatino / Fluorouracilo Tipo de estudio: Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: In Vivo Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article Pais de publicación: Grecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google